Matt Newby - Jun 3, 2022 Form 3 Insider Report for EAGLE MATERIALS INC (EXP)

Role: EVP & General Counsel
Signature: /s/ Matt Newby
Stock symbol: EXP
Transactions as of: Jun 3, 2022
Transactions value $: $0
Form type: 3
Date filed: 6/6/2022, 04:52 PM
Next filing: Apr 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	EXP	Common Stock						17.9K	Jun 3, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	EXP	Non-Qualified Stock Option (Right to Buy)							Jun 3, 2022	Common Stock	4.25K	$75.69	Direct	F2
holding	EXP	Non-Qualified Stock Option (Right to Buy)							Jun 3, 2022	Common Stock	3.01K	$100.88	Direct	F3
holding	EXP	Non-Qualified Stock Option (Right to Buy)							Jun 3, 2022	Common Stock	2.61K	$100.88	Direct	F4
holding	EXP	Non-Qualified Stock Option (Right to Buy)							Jun 3, 2022	Common Stock	3.17K	$106.24	Direct	F5
holding	EXP	Non-Qualified Stock Option (Right to Buy)							Jun 3, 2022	Common Stock	2.94K	$106.24	Direct	F6
holding	EXP	Non-Qualified Stock Option (Right to Buy)							Jun 3, 2022	Common Stock	3.86K	$91.58	Direct	F7
holding	EXP	Non-Qualified Stock Option (Right to Buy)							Jun 3, 2022	Common Stock	3.65K	$91.58	Direct	F8
holding	EXP	Non-Qualified Stock Option (Right to Buy)							Jun 3, 2022	Common Stock	2.72K	$60.21	Direct	F9
holding	EXP	Non-Qualified Stock Option (Right to Buy)							Jun 3, 2022	Common Stock	2.27K	$60.21	Direct	F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This number includes the following restricted shares: (a) 561 shares remaining from a grant awarded to the reporting person on 5/16/2019, the restrictions on which will lapse on 3/31/2023; (b) 2,740 shares remaining from a grant awarded to the reporting person on 5/19/2020, the restrictions on which will lapse ratably on March 31 of 2023 and 2024; (c) 2,370 shares remaining from a grant awarded to the reporting person on 5/19/2021, the restrictions on which will lapse ratably on March 31 of 2023, 2024 and 2025; and (d) 2,773 shares awarded to the reporting person on 5/19/2022, the restrictions on which will lapse ratably on March 31 of 2023, 2024, 2025 and 2026.
F2	On May 20, 2016, the reporting person was granted an option to purchase up to 4,308 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2017. On May 10, 2017, the performance conditions were determined to have been satisfied such that stock options vested as to 4,246 shares and currently all of these options are exercisable.
F3	On May 18, 2017, the reporting person was granted an option to purchase up to 3,126 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2018. On May 7, 2018, the performance conditions were determined to have been satisfied such that stock options vested as to 3,008 shares and currently all of these options are exercisable.
F4	On May 18, 2017 the reporting person was granted an option to purchase up to 2,605 shares of Common Stock, and currently all of these options are exercisable.
F5	On May 17, 2018, the reporting person was granted an option to purchase up to 3,528 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2019. On May 13, 2019, the performance conditions were determined to have been satisfied such that stock options vested as to 3,165 shares, all of which are currently exercisable.
F6	On May 17, 2018 the reporting person was granted an option to purchase up to 2,940 shares of Common Stock, and currently all of these options are exercisable.
F7	On May 16, 2019, the reporting person was granted an option to purchase up to 4,385 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2020. On May 4, 2020, the performance conditions were determined to have been satisfied such that stock options vested as to 3,859 shares. Currently 2,895 options are exercisable and the remaining options vest on March 31, 2023.
F8	On May 16, 2019 the reporting person was granted an option to purchase up to 3,654 shares of Common Stock, Currently 2,741 options are exercisable and the remaining options will vest on March 31, 2023.
F9	On May 19, 2020, the reporting person was granted an option to purchase up to 2,718 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2021. On May 6, 2021, the performance conditions were determined to have been satisfied such that stock options vested as to 2,718 shares. Currently 1,360 options are exercisable and the remaining options vest on March 31 of 2023 and 2024.
F10	On May 19, 2020 the reporting person was granted an option to purchase up to 2,265 shares of Common Stock, Currently 1,133 options are exercisable and the remaining options will vest ratably on March 31 of 2023 and 2024.